ImageneBio (IMA) Other Non Operating Income (2020 - 2025)
ImageneBio (IMA) posted Other Non Operating Income of $1.8 million for Q3 2025, down 60.98% sequentially from $4.7 million in Q2 2025, and up 253.98% YoY from $518953.6 in Q3 2024.
ImageneBio (IMA) Other Non Operating Income (2020 - 2025) Analysis & Trends
ImageneBio has reported Other Non Operating Income for 6 years, with the latest figure at $1.8 million in Q3 2025.
- Quarterly Other Non Operating Income rose 253.98% year-over-year to $1.8 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $10.3 million (up 1152.09% YoY) and the FY2024 annual result came in at $2.5 million, up 11545.45% from the prior year.
- Other Non Operating Income eased to $1.8 million in Q3 2025 per IMA's latest filing, from $4.7 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $4.7 million in Q2 2025 and troughed at -$1.2 million in Q3 2024.
- A 5-year average of $624578.9 and a median of $6000.0 in 2021 frame the typical range for Other Non Operating Income.
- The widest YoY moves for Other Non Operating Income: up 26957.14% in 2024, down 59550.0% in 2024.
- Over 5 years, Other Non Operating Income stood at $5000.0 in 2021, then jumped by 20240.0% to $1.0 million in 2022, then slumped by 101.38% to -$14000.0 in 2023, then surged by 26957.14% to $3.8 million in 2024, then plunged by 51.14% to $1.8 million in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.8 million, $4.7 million, and -$5000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | ImageneBio | 47.79 Mn | -87.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 3.76 Mn |
| Sep 30, 2024 | -1.19 Mn |
| Jun 30, 2024 | 235,000.00 |
| Mar 31, 2024 | -7,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | 566,000.00 |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 538,000.00 |
| Jun 30, 2022 | 460,000.00 |
| Mar 31, 2022 | -49,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 7,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 4,000.00 |
| Dec 31, 2020 | 2,000.00 |